drugset / Trial / NCT00909064
The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that Arixtra patients will be less likely to experience wound infection than patients who have received low-molecular weight heparin, coumadin or aspirin with mechanical compression.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fondaparinux | Other / unclassified | 2.5 mg | — |
Indications
No indication recorded.